CIK 0001849380 · <br>Emerging growth company
OneMedNet Corp
Sign in to watch- Ticker
- ONMD
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 862076743
- Phone
- 011-44-208-090-2009
- Business address
- TRIDENT COURT, 1 OAKCROFT ROAD, CHESSINGTON, SURREY, United Kingdom, KT9 1BD
- Former names
- Data Knights Acquisition Corp.
Securities
- ONMD Class A Common Stock Nasdaq
- ONMDW Warrant Nasdaq
- Open-market buys, last 90 days
- $1,089,999
- in 3 filings
- Open-market sales, last 90 days
- $103,052
- in 2 filings
Net +$986,947. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-06-19 | Yu Jeffrey Chief Medical Officer | Conversion | +1,828,279 | $0.71 | $1.3M | 5,070,744 |
| 2025-06-19 | Kosasa Thomas Director | Conversion | +2,123,424 | $0.75 | $1.6M | 11,097,304 |
| 2025-06-19 | Kosasa Thomas Director | Conversion | +2,865,016 | $0.71 | $2.0M | 13,962,320 |
| 2025-06-17 | Yu Jeffrey Chief Medical Officer | Conversion | +479,270 | $1.14 | $546K | 3,242,465 |
| 2025-06-17 | Yu Jeffrey Chief Medical Officer | Conversion · Senior Secured Convertible Note | −479,270 | $1.14 | $546K | 0 |
| 2025-06-17 | Kosasa Thomas Director | Conversion | +493,056 | $1.14 | $562K | 8,973,880 |
| 2025-06-17 | Kosasa Thomas Director | Conversion · Senior Secured Convertible Note | −493,056 | 0 | ||
| 2025-06-17 | Green Aaron Chief Executive Officer | Conversion | +240,425 | $1.14 | $274K | 885,425 |
| 2025-06-17 | Green Aaron Chief Executive Officer | Conversion · Senior Secured Convertible Note | −240,425 | 0 | ||
| 2025-06-16 | Kosasa Thomas Director | Purchase | +55,000 | $0.38 | $21K | 8,480,824 |
| 2025-05-09 | Yu Jeffrey Chief Medical Officer | Purchase · Warrants (Right to Buy | +5,946 | $0.03 | $178 | 5,946 |
| 2025-04-21 | Kosasa Thomas Director | Purchase | +47,000 | $0.49 | $23K | 8,425,824 |
| 2025-01-31 | Golden Robert Lawrence Chief Financial Officer | Grant or award | +24,272 | 169,572 | ||
| 2025-01-01 | Zeinfeld Andrew B Director | Grant or award | +82,143 | 336,525 | ||
| 2025-01-01 | Clarke Jair Director | Grant or award | +82,143 | 93,485 | ||
| 2024-12-18 | Yu Jeffrey Chief Medical Officer | Purchase | +100 | $0.99 | $99 | 2,763,195 |
| 2024-11-20 | Casaburi Eric Director | Purchase | +1,300 | $0.87 | $1K | 55,475 |
| 2024-11-12 | Casaburi Eric Director | Purchase | +500 | $0.85 | $425 | 54,175 |
| 2024-10-01 | Yu Jeffrey Chief Medical Officer | Grant or award | +230,769 | $0.57 | $132K | 2,763,095 |
| 2024-10-01 | McCraw Sherry Coonse Director | Grant or award | +11,342 | 11,342 |
Page 4 of 7 · 137 trades